ABOUT MEDICILON

Medicilon is an integrated biomedical contract research organization (CRO), providing comprehensive one-step new drug R&D for pharmaceutical enterprises and scientific research institutions around the world.Our services cover the entire preclinical new drug research process, including drug discovery, pharmaceutical research, and preclinical research.Drug discovery includes: Protein target verification, structural biologychemical synthesis, active screening and optimization of compounds; Pharmaceutical research includes: API and preparation process, research on quality standards and stability; Pre-clinical research includes: Pharmacodynamics pharmacokinetics toxicology, and drug safety evaluation.

Based on key links of drug R&D, we focus on the demand for innovation and the development of the global pharmaceutical industry. With our experience in serving domestic and foreign biomedical industries, we have built an integrated technical platform covering key technologies in drug discovery, pharmaceutical research, and preclinical research, in a bid to provide comprehensive preclinical new drug R&D for the global biomedical industry.